{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:09:04Z","timestamp":1759342144700},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jbspin.2014.12.001","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T15:40:29Z","timestamp":1422027629000},"page":"196-199","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment of pseudo Felty's syndrome: Is there a place for rituximab?"],"prefix":"10.1016","volume":"82","author":[{"given":"Frank","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.12.001_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-0172(91)90002-H","article-title":"Felty's and pseudo-Felty's Syndromes","volume":"21","author":"Rosensteinband","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0010","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar2424","article-title":"Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy","volume":"10","author":"Prochorec-Sobieszek","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/asheducation.V2012.1.652.3798658","article-title":"Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment","volume":"2012","author":"Zhang","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0020","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0025","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2013-03-491464","article-title":"Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy","volume":"122","author":"Cornec","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0035","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1186\/ar3541","article-title":"Frequency of Th17 CD20 cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects","volume":"13","author":"Eggleton","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0045","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.24998","article-title":"Depletion of functionally active CD20T cells by rituximab treatment","volume":"60","author":"Wilk","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0050","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.38107","article-title":"Rituximab induced T cell depletion in patients with rheumatoid arthritis: association with clinical response","volume":"65","author":"Melet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2009.03.515","article-title":"T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia","volume":"132","author":"Shah","year":"2009","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","article-title":"Large granular lymphocyte leukemia","volume":"11","author":"Sokol","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2014.02.001","article-title":"The pathogenesis and treatment of large granular lymphocyte leukemia","author":"Steinway","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3899\/jrheum.100729","article-title":"Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab","volume":"38","author":"Iwata","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semarthrit.2011.08.008","article-title":"Biological agents in the management of Felty's syndrome: a systematic review","volume":"41","author":"Narv\u00e1ez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.12.001_bib0080","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jbspin.2012.01.013","article-title":"One case of Felty's syndrome efficiently treated with rituximab","volume":"79","author":"Tomi","year":"2012","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T07:49:57Z","timestamp":1598687397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1297319X14002747"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.12.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pseudo Felty's syndrome: Is there a place for rituximab?","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}